The pain management devices market is projected to witness significant growth from 2025 to 2032, driven by the rising prevalence of chronic pain, ongoing product innovations, and heightened awareness of treatment options. Increasing demand for minimally invasive solutions, alongside the influence of educational and awareness programs, is boosting adoption, fostering technological advancements, and enhancing patient outcomes.
DelveInsight’s Pain Management Devices Market Insights report delivers a comprehensive analysis of the current and forecasted market, highlighting individual leading companies’ market shares, key challenges, market drivers, barriers, trends, and notable players operating in the sector.
Pain Management Devices Market Summary
- The global pain management devices market is projected to grow from USD 5.2 billion in 2024 to USD 9.3 billion by 2032, reflecting robust and sustained expansion.
- The market is expected to register a CAGR of ~8% during the forecast period from 2025 to 2032.
- Leading companies in the pain management devices sector include Abbott Laboratories, Smith’s Medical, B. Braun SE, Baxter International, Boston Scientific Corp., Avanos Medical, Inc., Medtronic, Nevro Corp., ICU Medical, Inc., Omron Corporation, Stimwave LLC, Nipro, O&M Halyard, EndoStim Inc., Nalu Medical, Inc., Micrel Medical Devices SA, DyAnsys, Inc., NanoVibronix, Inc., Zynex Inc., and others.
- Among all regions, North America is anticipated to experience the fastest growth during the forecast period.
- In terms of device type, Neurostimulation devices accounted for the largest market share in 2024.
Read more about the latest insights in the pain management devices market with a snapshot of key highlights from the Global Pain Management Devices Market Forecast Report
Key Factors Contributing to the Rise in Growth of the Pain Management Devices Market
The Growing Prevalence of Chronic Pain and Related Conditions
The increasing prevalence of chronic pain is driven by multiple interconnected demographic and health trends. As global life expectancy rises, aging populations experience a higher incidence of age-related conditions such as osteoarthritis, musculoskeletal disorders, and neuropathic pain. Chronic diseases like diabetes and cancer further contribute to persistent pain through complications including diabetic neuropathy and cancer-related pain. Additionally, obesity exacerbates stress on joints and the skeletal system, intensifying pain in areas like the back, knees, and hips. Modern lifestyle factors, including sedentary habits, prolonged screen time, and repetitive occupational movements, also contribute to musculoskeletal issues and repetitive strain injuries, collectively driving the demand for effective, non-pharmacological pain management solutions.
The Shift Away from Opioid-Based Pain Management
The global opioid crisis, characterized by widespread addiction, misuse, and overdose deaths, has highlighted the risks of traditional pain medications and prompted a move toward safer, non-addictive alternatives. This shift has encouraged the adoption of multimodal pain management strategies that combine non-opioid medications, physical therapy, and medical devices such as TENS units to manage pain while minimizing systemic side effects like drowsiness and nausea. Consequently, the opioid crisis has become a significant driver for the pain management devices market, fostering innovation in non-pharmacological pain relief solutions.
Technological Advancements and Innovation
Innovations in neuromodulation, including closed-loop neurostimulation systems and miniaturized implantable devices, alongside the emergence of smart wearable pain management tools and AI-driven digital health platforms, are enhancing the personalization, effectiveness, and convenience of pain management therapies. These technological developments allow for more precise, less invasive pain control and improved patient outcomes.
Take a sneak peek at the pain management devices market dynamics @ Pain Management Devices Market Trends
Regional Pain Management Devices Market Insights
North America, led by the US, accounted for ~45% of the global pain management devices market in 2024. Key drivers include the rising prevalence of chronic pain, continuous product innovation and regulatory approvals, and supportive government initiatives. Advanced, minimally invasive devices integrating AI and closed-loop systems are reshaping treatment paradigms, enabling more tailored therapies.
In Europe, market growth is steady, reflecting evolving clinical practices and increasing adoption of technological advancements. The Asia-Pacific region is expected to experience the fastest growth, driven by demographic shifts, rising healthcare investments, and rapid economic development.
Learn why North America is driving growth in the pain management devices market with a snapshot of the Pain Management Devices Market Share
Recent Developmental Activities in the Pain Management Devices Market
- August 2025: FDA cleared the NeuroOne OneRF™ Radiofrequency Ablation System for trigeminal neuralgia via minimally invasive RF ablation; commercial launch planned for fall 2025.
- May 2025: electroCore, Inc. completed its merger with NeuroMetrix, Inc., expanding its bioelectronic therapy portfolio and presence in chronic pain management within the VA Hospital System.
- April 2025: Globus Medical, Inc. finalized the acquisition of Nevro Corp., enhancing its solutions for chronic pain management.
What are Pain Management Devices?
Pain management devices are medical instruments designed to alleviate chronic or acute pain through non-invasive or minimally invasive approaches. These devices modulate neural activity, deliver targeted stimulation, or provide localized therapy to reduce pain perception. Common categories include neurostimulation devices (spinal cord stimulators, TENS units), analgesic infusion pumps, and radiofrequency ablation devices. They are widely used for neuropathic pain, musculoskeletal disorders, cancer-related pain, and post-surgical discomfort, offering alternatives or complements to pharmacological treatments, especially amidst growing concerns over opioid dependency.
Pain Management Devices Market Assessment
Pain Management Devices Market Segmentation By Device Type:
- Electrical Stimulation Devices: Neurostimulation Devices (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, and Others), Transcutaneous Electrical Nerve Stimulation (TENS), and Others
- Analgesic Infusion Pumps: Intrathecal Infusion Pumps, External Infusion Pumps
- Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices
- Others
Pain Management Devices Market Segmentation By Application:
- Musculoskeletal Pain
- Cancer Pain
- Neuropathic Pain
- Others
Pain Management Devices Market Segmentation By End-User:
- Hospitals
- Specialty Clinics
- Rehabilitation Centers/Physiotherapy Centers
- Homecare Settings
- Others
Pain Management Devices Market Segmentation By Geography:
- North America
- Europe
- Asia-Pacific
- Rest of World
The report also includes Porter’s Five Forces Analysis, detailed Product Profiles, Case Studies, KOL’s Views, and Analyst’s Perspective to provide a comprehensive understanding of market trends, competitive positioning, and strategic opportunities
Discover which MedTech key players in the pain management devices market are poised to become trendsetters @ Pain Management Devices Market Analysis
About DelveInsight
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions.
